Stefan Schneider
Prof. Dr.
Stefan W. Schneider
  • Klinikdirektor
  • Facharzt für Haut- und Geschlechtskrankheiten
Arbeitsbereich

Standort

W14, EG
Sprachen
Deutsch (Muttersprache)
Englisch

Fachgebiete

Tätigkeitsschwerpunkte

Publikationen

2017

Biphasic influence of Staphylococcus aureus on human epidermal tight junctions
Bäsler K, Galliano M, Bergmann S, Rohde H, Wladykowski E, Vidal-Y-Sy S, Guiraud B, Houdek P, Schüring G, Volksdorf T, Caruana A, Bessou-Touya S, Schneider S, Duplan H, Brandner J
ANN NY ACAD SCI. 2017 [Epub ahead of print].

D-dimers in malignant melanoma: Association with prognosis and dynamic variation in disease progress
Desch A, Gebhardt C, Utikal J, Schneider S
INT J CANCER. 2017;140(4):914-921.

Treating onychomycosis with the short-pulsed 1064-nm-Nd:YAG laser: results of a prospective randomized controlled trial
Karsai S, Jäger M, Oesterhelt A, Weiss C, Schneider S, Jünger M, Raulin C
J EUR ACAD DERMATOL. 2017;31(1):175-180.

2016

Surgical procedures in patients with haemophilic arthropathy of the ankle
Barg A, Morris S, Schneider S, Phisitkul P, Saltzman C
HAEMOPHILIA. 2016;22(3):e156-76.

Leda-1/Pianp is targeted to the basolateral plasma membrane by a distinct intracellular juxtamembrane region and modulates barrier properties and E-Cadherin processing
Evdokimov K, Biswas S, Schledzewski K, Winkler M, Gorzelanny C, Schneider S, Goerdt S, Géraud C
BIOCHEM BIOPH RES CO. 2016;475(4):342-9.

Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis
Goertz L, Schneider S, Desch A, Mayer F, Koett J, Nowak K, Karampinis I, Bohlmann M, Umansky V, Bauer A
ONCOTARGET. 2016;7(42):68527-68545.

Silver nanoparticle-enriched diamond-like carbon implant modification as a mammalian cell compatible surface with antimicrobial properties
Gorzelanny C, Kmeth R, Obermeier A, Bauer A, Halter N, Kümpel K, Schneider M, Wixforth A, Gollwitzer H, Burgkart R, Stritzker B, Schneider S
SCI REP-UK. 2016;6:22849.

Monocyte Induction of E-Selectin-Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade
Häuselmann I, Roblek M, Protsyuk D, Huck V, Knopfova L, Grässle S, Bauer A, Schneider S, Borsig L
CANCER RES. 2016;76(18):5302-12.

From morphology to biochemical state - intravital multiphoton fluorescence lifetime imaging of inflamed human skin
Huck V, Gorzelanny C, Thomas K, Getova V, Niemeyer V, Zens K, Unnerstall T, Feger J, Fallah M, Metze D, Ständer S, Luger T, Koenig K, Mess C, Schneider S
SCI REP-UK. 2016;6:22789.

Hybrid electrospun chitosan-phospholipids nanofibers for transdermal drug delivery
Mendes A, Gorzelanny C, Halter N, Schneider S, Chronakis I
INT J PHARMACEUT. 2016;510(1):48-56.

Nucleoside diphosphate kinase B deficiency causes a diabetes-like vascular pathology via up-regulation of endothelial angiopoietin-2 in the retina
Qiu Y, Zhao D, Butenschön V, Bauer A, Schneider S, Skolnik E, Hammes H, Wieland T, Feng Y
ACTA DIABETOL. 2016;53(1):81-9.

Association of Cole disease with novel heterozygous mutations in the somatomedin-B domains of the ENPP1 gene: necessary, but not always sufficient
Schlipf N, Traupe H, Gilaberte Y, Peitsch W, Hausser I, Oji V, Schmieder A, Schneider S, Demmer P, Rösler B, Fischer J
BRIT J DERMATOL. 2016;174(5):1152-6.

Anticoagulation with rivaroxaban for livedoid vasculopathy (RILIVA), a multicentre, single-arm, open-label, phase 2a, proof-of-concept trial
Weishaupt C, Strölin A, Kahle B, Kreuter A, Schneider S, Gerss J, Eveslage M, Drabik A, Goerge T
LANCET HAEMATOL. 2016;3(2):e72-9.

2015

Force-sensitive autoinhibition of the von Willebrand factor is mediated by interdomain interactions
Aponte-Santamaria C, Huck V, Posch S, Bronowska A, Grässle S, Brehm M, Obser T, Schneppenheim R, Hinterdorfer P, Schneider S, Baldauf C, Grater F
BIOPHYS J. 2015;108(9):2312-21.

von Willebrand factor fibers promote cancer-associated platelet aggregation in malignant melanoma of mice and humans
Bauer A, Suckau J, Frank K, Desch A, Goertz L, Wagner A, Hecker M, Goerge T, Umansky L, Beckhove P, Utikal J, Gorzelanny C, Diaz-Valdes N, Umansky V, Schneider S
BLOOD. 2015;125(20):3153-63.

Monitoring wound healing by multiphoton tomography/endoscopy
König K, Weinigel M, Bückle R, Kaatz M, Hipler C, Zens K, Schneider S, Huck V
Proc. SPIE. 2015;9303:93030F-93030F-6.

Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells
Möller K, Adolph O, Grunow J, Elrod J, Popa M, Ghosh S, Schwarz M, Schwale C, Grässle S, Huck V, Bruehl C, Wieland T, Schneider S, Nobiling R, Wagner A, Hecker M
THROMB HAEMOSTASIS. 2015;113(5):1095-108.

2014

The various states of von Willebrand factor and their function in physiology and pathophysiology
Huck V, Schneider M, Gorzelanny C, Schneider S
THROMB HAEMOSTASIS. 2014;111(4):598-609.

Desmoglein 2 depletion leads to increased migration and upregulation of the chemoattractant secretoneurin in melanoma cells
Peitsch W, Doerflinger Y, Fischer-Colbrie R, Huck V, Bauer A, Utikal J, Goerdt S, Schneider S
PLOS ONE. 2014;9(2):e89491.

Early treatment with rutoside and ascorbic acid is highly effective for progressive pigmented purpuric dermatosis
Schober S, Peitsch W, Bonsmann G, Metze D, Thomas K, Goerge T, Luger T, Schneider S
J DTSCH DERMATOL GES. 2014;12(12):1112-9.

Melanoma-derived IL-1 converts vascular endothelium to a proinflammatory and procoagulatory phenotype via NFkappaB activation
Strozyk E, Desch A, Poeppelmann B, Magnolo N, Wegener J, Huck V, Schneider S
EXP DERMATOL. 2014;23(9):670-6.

2013

Blood-clotting-inspired reversible polymer-colloid composite assembly in flow
Chen H, Fallah M, Huck V, Angerer J, Reininger A, Schneider S, Schneider M, Alexander-Katz A
NAT COMMUN. 2013;4:1333.

Circulating but not immobilized N-deglycosylated von Willebrand factor increases platelet adhesion under flow conditions
Fallah M, Huck V, Niemeyer V, Desch A, Angerer J, McKinnon T, Wixforth A, Schneider S, Schneider M
BIOMICROFLUIDICS. 2013;7(4):44124.

2012

Highly invasive melanoma cells activate the vascular endothelium via an MMP-2/integrin alphavbeta5-induced secretion of VEGF-A
Desch A, Strozyk E, Bauer A, Huck V, Niemeyer V, Wieland T, Schneider S
AM J PATHOL. 2012;181(2):693-705.

Development of a novel two-channel microfluidic system for biomedical applications in cancer research
Rajabi T, Huck V, Ahrens R, Apfel M, Kim S, Schneider S, Guber A
BIOMED ENG-BIOMED TE. 2012;57:921-922.

2011

Intravital multiphoton tomography as an appropriate tool for non-invasive in vivo analysis of human skin affected with atopic dermatitis
Huck V, Gorzelanny C, Thomas K, Mess C, Dimitrova V, Schwarz M, Riemann I, Niemeyer V, Luger T, König K, Schneider S
Proc. SPIE. 2011;7883:78830R-78830R.

2010

5D-intravital tomography as a novel tool for non-invasive in-vivo analysis of human skin
König K, Weinigel M, Breunig H, Gregory A, Fischer P, Kellner-Höfer M, Bückle R, Schwarz M, Riemann I, Stracke F, Huck V, Gorzelanny C, Schneider S
Proc. SPIE. 2010;7555:75551I-75551I.

2007

Microfluidic reveals generation of platelet-strings on tumor-activated endothelium
Goerge T, Kleineruschkamp F, Barg A, Schnaeker E, Huck V, Schneider M, Steinhoff M, Schneider S
THROMB HAEMOSTASIS. 2007;98(2):283-6.

Delay of acute intracellular pH recovery after acidosis decreases endothelial cell activation
Huck V, Niemeyer A, Goerge T, Schnaeker E, Ossig R, Rogge P, Schneider M, Oberleithner H, Schneider S
J CELL PHYSIOL. 2007;211(2):399-409.

Letzte Aktualisierung aus dem FIS: 19.10.2017 - 00:01 Uhr